Viracta Therapeutics Buy Hold or Sell Recommendation
| VIRXDelisted Stock | USD 0.03 0 7.38% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Viracta Therapeutics is 'Not Rated'. A buy or sell recommendation is an automated directive regarding whether to purchase or sell Viracta Therapeutics given historical horizon and risk tolerance. When we issue a 'buy' or 'sell' recommendation for Viracta Therapeutics, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. In addition, we conduct extensive research on individual companies such as Viracta and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Viracta Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
Viracta |
Execute Viracta Therapeutics Buy or Sell Advice
The Viracta recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Viracta Therapeutics. Macroaxis does not own or have any residual interests in Viracta Therapeutics or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Viracta Therapeutics' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Not Rated
Viracta Therapeutics Trading Alerts and Improvement Suggestions
| Viracta Therapeutics is not yet fully synchronised with the market data | |
| Viracta Therapeutics generated a negative expected return over the last 90 days | |
| Viracta Therapeutics has high historical volatility and very poor performance | |
| Viracta Therapeutics has some characteristics of a very speculative penny stock | |
| Viracta Therapeutics has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (51.06 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Viracta Therapeutics currently holds about 83.14 M in cash with (39.89 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.21, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
Viracta Therapeutics Returns Distribution Density
The distribution of Viracta Therapeutics' historical returns is an attempt to chart the uncertainty of Viracta Therapeutics' future price movements. The chart of the probability distribution of Viracta Therapeutics daily returns describes the distribution of returns around its average expected value. We use Viracta Therapeutics price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Viracta Therapeutics returns is essential to provide solid investment advice for Viracta Therapeutics.
| Mean Return | -1.97 | Value At Risk | -14.49 | Potential Upside | 12.50 | Standard Deviation | 11.91 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Viracta Therapeutics historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Note: Disposition of 9034 shares by Pomerantz Roger of Viracta Therapeutics subject to Rule 16b-3 [view details]
Viracta Therapeutics Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Viracta . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Viracta Therapeutics Buy or Sell Advice
When is the right time to buy or sell Viracta Therapeutics? Buying financial instruments such as Viracta Pink Sheet isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Viracta Therapeutics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Entertainment Thematic Idea Now
Entertainment
Companies from entertainment industry including show business, news and media. The Entertainment theme has 45 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Entertainment Theme or any other thematic opportunities.
| View All Next | Launch |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Other Consideration for investing in Viracta Pink Sheet
If you are still planning to invest in Viracta Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Viracta Therapeutics' history and understand the potential risks before investing.
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum |